SqueezeRadar
Back to radar

OCGN

Moderate · 44/100

Ocugen, Inc.

Healthcare · Biotechnology

$1.49-1.32% todayupdating…
FinvizShort InterestYahoo Finance
Clean Setupconfluence across 5signals
Squeeze fuel
  • 26% short float
  • 17 days to cover
  • fails-to-deliver rising
  • bullish gamma setup
  • insider buying (1 purchase)
Loading chart…

Key Statistics

Short Interest
25.71%
% of float
Days to Cover
16.7
days
Daily Short Vol
44.2%
45% 5d avg · FINRA
Fails to Deliver
9K
rising balance ↑ · SEC
Volatility
Normal
Bollinger / Keltner
Float
316.84M
shares
Cost to Borrow
—
CTB fee · IBKR
Shares Available
—
to borrow · IBKR
Rel. Volume
0.12×
vs 20-day avg
RSI (14)
53.3
Neutral
Call/Put Ratio
4.24
OI ratio
Shares Short
86.56M
shares
Prior Month Short
—
shares
WSB Mentions
None this week
r/WallStreetBets · 7 days
Market Cap
504.40M
USD
Volume
1.23M
today
Avg Volume
7.91M
30-day avg
50-day MA
$1.43
Price above ↑
200-day MA
—
Price below ↓

ⓘ Short interest from FINRA via Yahoo Finance (biweekly, ~2–3 week lag). Cost-to-borrow & shares-available from the Interactive Brokers feed via iBorrowDesk — the free proxy for utilization. Daily short-sale volume from the FINRA consolidated daily file (2026-07-02) — the fresh short pulse vs the ~2-week-lagged biweekly SI. SEC FTD files are aggregate balances and can lag the trading setup. Price, volume, and technicals from market data. Last updated: Jul 6, 02:17 PM

44/ 100
Squeeze Confidence
44/ 100
Moderate
Short Float %25.71%
16 / 25

% of free float currently sold short

Days to Cover16.7 days
17 / 20

Shares short ÷ avg daily volume

Float Size316.84M shares
0 / 15

Freely tradeable shares — smaller = more volatile

Borrow PressureCTB n/a
0 / 22

Cost-to-borrow + availability — the utilization proxy (IBKR feed)

Relative Volume0.12×
0 / 8

Current volume ÷ 20-day average volume

MomentumRSI 53.3
3 / 6

RSI(14) + price vs. 50/200-day moving averages

Options Flow4.24 C/P
4 / 4

Call / Put open interest ratio (gamma fuel)

Daily Short Pressure44.2% of daily vol
0 / 6

Short volume ÷ total volume (FINRA daily) — the fresh short pulse vs the biweekly SI

Rising FTD balance — SEC aggregate fails-to-deliver balances are rising versus the prior file. This is settlement-pressure context, not proof of naked shorting. Score boosted +2.
Insider buying — 1 recent open-market insider purchase in Form 4 filings. Score boosted +2.
50-day MA: Above ↑
200-day MA: Below ↓

What to Watch

  • ●Short interest at 25.71% of float — elevated level
  • ●16.7 days to cover — shorts would need sustained volume to exit
  • ○316.84M share float — large float dampens squeeze dynamics
  • ○Borrow data n/a — easy to borrow: little borrow-side pressure
  • ○Volume 0.1× normal — quiet — awaiting catalyst
  • ●Price above 50-day MA — momentum shifted bullish, shorts face stop-loss pressure

Squeeze Conditions Checklist

✓
High Short Interest (>20%)
✓
Long Days to Cover (>7)
✗
Low Float (<20M shares)
✗
Hard to Borrow (high CTB / scarce supply)
✗
Volume Spike (RVOL >2.5×)
✓
Price above 50-day MA
✗
RSI Building Momentum (>60)
✓
Call-Heavy Options Flow
✗
Short Interest Increasing
✗
Fresh Catalyst (recent news)

Catalyst · fuel needs ignition

Eye gene therapy for blindness hits stage at three June events

Stock Titan· 34d agostale

SEC Filings · last 45 days

1 insider buy

Gamma / Max Pain · exp 2026-07-17

Bullish gamma setup — call-heavy and trading below max pain. As price rises, dealers must buy to stay hedged — fuel on top of the squeeze.
Max Pain
$1.5
-0.7% vs price
Call / Put OI
4.24
16.5K / 3.9K
Call Wall
$2
heaviest call OI above
Put Support
$1
heaviest put OI below